Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN11 | Q06124 | 1/20 | 0.34 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.33 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | RORC | P51449 | 1/20 | 0.30 |
| ▸ | HSD11B1 | P28845 | 3/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10129621 | 0.81 | MEN1 (0.46) | MEN1KMT2AHSD11B1 | |
| Hydrochloric Acid SCHEMBL496002 | 0.79 | MEN1 (0.44) | MEN1KMT2AHSD11B1 | |
| SCHEMBL5031120 | 0.76 | HSD11B1 (0.43) | DPP9DPP7MEN1KMT2AHSD11B1 | |
| SCHEMBL5027628 | 0.76 | HSD11B1 (0.39) | DPP9DPP7MEN1KMT2AHSD11B1 | |
| SCHEMBL15742291 | 0.76 | HSD11B1 (0.46) | DPP9DPP7KMT2AHSD11B1 | |
| Hydrochloric Acid SCHEMBL6432974 | 0.74 | HSD11B1 (0.44) | DPP9DPP7KMT2AHSD11B1 | |
| SCHEMBL5031162 | 0.74 | HSD11B1 (0.45) | MEN1KMT2AHSD11B1 | |
| SCHEMBL8050734 | 0.73 | MEN1 (0.41) | DPP9DPP7MEN1KMT2AHSD11B1 | |
| SCHEMBL3317554 | 0.72 | FASN (0.41) | — | |
| SCHEMBL16207693 | 0.72 | HSD11B1 (0.50) | DPP9DPP7HSD11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2029551-B1 | PYRIDINONE AND PYRIDAZINONE DERIVATIVES AS INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE (PARP) | MSD ITALIA SRL (IT) | 2018-10-31 | — | — | EP | disclosed |
| US-8188084-B2 | Pyridinone and pyridazinone derivatives as inhibitors of poly (ADP-ribose) polymerase (PARP) | ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA. (IT) | 2012-05-29 | — | — | US | disclosed |
| US-20090176765-A1 | Pyridinone and Pyridazinone Derivatives as Inhibitors of Poly (Adp-Ribose) Polymerase (Parp) | MSD ITALIA S.R.L. (IT) | 2009-07-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090176765-A1 | Pyridinone and Pyridazinone Derivatives as Inhibitors of Poly (Adp-Ribose) Polymerase (Parp) | PARP1, PARP2, PARP3 | PTPN11 4290/4885DPP9 1117/4885DPP7 1107/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.